Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum-Reference-Cited by-同舟云学术

Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum

Published:2022-01 Issue:10321 Volume:399 Page:234-236
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Dejnirattisai Wanwisa,Shaw Robert H,Supasa Piyada,Liu Chang,Stuart Arabella SV,Pollard Andrew J,Liu Xinxue,Lambe Teresa,Crook Derrick,Stuart Dave I,Mongkolsapaya Juthathip,Nguyen-Van-Tam Jonathan S,Snape Matthew D,Screaton Gavin R

Publisher

Elsevier BV

Subject

General Medicine

Reference6 articles.

1. Receptor binding and escape from beta antibody responses drive omicron-B.1.1.529 evolution;Zahradník;bioRxiv,2021

2. Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial;Stuart;Lancet,2021

3. SARS-CoV-2 omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection;Cele;medRxiv,2021

4. SARS-CoV-2 B.1.1.529 variant (omicron) evades neutralization by sera from vaccinated and convalescent individuals;Roessler;medRxiv,2021

5. Reduced neutralization of SARS-CoV-2 omicron variant by vaccine sera and monoclonal antibodies;Wilhelm;medRxiv,2021

Cited by 304 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infection-mediated immune response in SARS-CoV-2 breakthrough infection and implications for next-generation COVID-19 vaccine development;Vaccine;2024-02

2. Clinical Characteristics of Children Infected with SARS-CoV-2 Omicron (B.1.1.529) in China’s Shanghai;International Journal of General Medicine;2024-01

3. Brewpitopes: a pipeline to refine B-cell epitope predictions during public health emergencies;Frontiers in Immunology;2023-12-06

4. Effectiveness of bivalent mRNA vaccines against medically attended symptomatic SARS-CoV-2 infection and COVID-19-related hospital admission among SARS-CoV-2-naive and previously infected individuals: a retrospective cohort study;The Lancet Infectious Diseases;2023-12

5. Estimation of waning vaccine effectiveness from population-level surveillance data in multi-variant epidemics;Epidemics;2023-12